Insider Holders & Insider Ownership - GT Biopharma Inc. (GTBP)

List of insiders holdings for GT Biopharma Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1Saloff David
CEO, Chairman of the Board
2012-05-30 16:58:1227,650,684
0
27,650,684Form 4
2Clarence-Smith Kathleen
CEO
10% Owner
2017-12-01 17:25:398,505,633
0
8,505,633Form 3
3Silverman Mark J
10% Owner
2017-12-01 19:29:248,172,079
0
8,172,079Form 13G
4Cataldo Tony
CEO
10% Owner
2020-06-04 17:15:286,500,000
0
6,500,000Form 4
5Weldon Steven W
Former Officer and Director
Director
2020-12-23 16:24:423,720,000
0
3,720,000Form 4
6Theorem Group LLC
10% Owner
2017-11-14 10:15:233,540,130
0
3,540,130Form 13G
7HAUSMAN MARVIN S MD
President & CEO
2008-02-08 12:44:252,344,080
0
2,344,080Form 5
8Landes Bernard
President
2010-03-22 19:39:472,220,453
0
2,220,453Form 3
9ROGERS RAY R
CEO/Chairman of the Board
2003-12-11 15:10:191,827,988
0
1,827,988Form 4/A
10Urbanski Raymond W.
CEO
2019-03-19 14:38:041,351,918
0
1,351,918Form 4
11Guillen Steven T
President & CEO
2005-12-30 17:18:501,100,000
0
1,100,000Form 4
12Post Gary M
Former Director and Secretary
2010-09-02 18:05:28900,000
0
900,000Form 4
13ELLIS SHARON
Chief Operational & Financial
2003-12-11 19:30:58885,000
0
885,000Form 4
14Ohri Manu
CFO & Secretary
2023-08-15 19:26:31200,000
550,000
750,000Form 4
15SHROTRIYA RAJESH C MD
Director
2023-02-01 06:02:39500,000
0
500,000Form 4
16Wendel Bruce
Director
2023-02-01 06:01:27500,000
0
500,000Form 4
17REPINE JOHN E
Director
2007-11-13 14:48:31482,187
0
482,187Form 4
18RODELL TIMOTHY C JR
Director
2005-12-30 17:24:28455,237
0
455,237Form 4
19WOLF THOMAS M
Director
2003-12-30 12:03:21433,626
0
433,626Form 4
20NEILL SYDNEY COLIN
Director
2007-11-13 14:31:02432,500
0
432,500Form 4
21Breen Michael Martin
CEO and Director
2025-09-08 17:45:43300,000
0
300,000Form 4
22Eaton Kenneth Haynes
Director
2011-07-07 19:20:21250,000
0
250,000Form 3
23DUBE ANSHUMAN
Director
2011-05-24 19:50:440
250,000
250,000Form 4
24HOOG THOMAS W
Director
2011-02-08 15:46:30250,000
0
250,000Form 3
25Handelman Michael D
Chief Financial Officer
2010-03-22 19:52:13250,000
0
250,000Form 3
26CENTRON MICHAEL D
VP & CFO
2006-08-02 19:02:01250,000
0
250,000Form 4
27Choy Gavin
Acting Chief Financial Officer
2022-02-14 16:09:22227,500
0
227,500Form 4
28BRISTOL INVESTMENT FUND LTD
BRISTOL CAPITAL LLC
10% Owner
2025-06-02 19:46:09150,000
0
150,000Form 13G
29BRISTOL INVESTMENT FUND LTD
10% Owner
2025-06-02 19:46:09150,000
0
150,000Form 13G
30BRUINSMA GOSSE B
Chairman, Acting CEO
2004-10-13 17:46:27135,000
0
135,000Form 4
31DAVIS RICHARD A
Director
2004-06-30 11:48:00107,147
0
107,147Form 4/A
32ODonnell Manus H
Acting Chief Operating Officer
2004-12-27 16:37:45100,000
0
100,000Form 4
33URBAN ALAN LOUIS
Chief Financial Officer
2025-09-08 17:45:41100,000
0
100,000Form 4
34PRYOR WILLIAM G
Director
2003-12-08 21:30:5887,602
0
87,602Form 4
35FERRIS STEVEN H
Director
2004-10-13 17:45:3285,000
0
85,000Form 4
36VLAK GERARD J M
Director
2004-10-13 17:44:0185,000
0
85,000Form 4
37CASAMENTO CHARLES J
Director
2025-09-08 17:45:4062,500
0
62,500Form 4
38Berk Gregory
Pres. of R&D, CMO
2022-07-19 21:44:5550,000
0
50,000Form 4
39SPOLAR MATTHEW R
Director
2007-11-13 14:36:3735,000
0
35,000Form 4
40WEBB TED FORD
Director
2003-12-09 15:07:0331,754
0
31,754Form 4/A
41Kramer Hilary
Director
2025-09-08 17:45:3831,250
0
31,250Form 4
42Mun-Gavin David C.
Director
2025-09-08 17:45:4431,250
0
31,250Form 4
43Ritter Andrew J
Director
2025-05-29 16:15:100
0
0Form 3
44Cross Shawn
Chief Executive Officer
2018-03-16 17:14:200
0
0Form 3
45AXONYX INC
HAUSMAN MARVIN S MD
10% Owner
2008-10-03 20:29:420
0
0Form 13D